Highlights
ASX: IMU       IMUGENE LIMITED
Last Price Today's Change   Day's Range   Trading Volume
0.053   +0.008 (17.78%)  0.043 - 0.063  258,815,454

Overview

 
Avg Volume (4 weeks):46,827,416
4 Weeks Range:0.02 - 0.063
4 Weeks Price Volatility (%):
76.74%
52 Weeks Range:0.013 - 0.063
52 Weeks Price Volatility (%):
80.00%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Imugene Limited is an immuno-oncology focused biopharmaceutical company. The Company is engaged in the research and development of human epidermal growth factor receptor 2 positive (HER2 +ve), and gastric and breast cancer vaccines. The Company is also engaged in the research, development and commercialization of health technologies. HER-Vaxx is a cancer immunotherapy designed to treat tumors that over-express the HER-2/neu receptor, such as gastric, breast, ovarian, lung and pancreatic cancers. HER-Vaxx has completed a Phase I clinical trial with over 10 HER-2 positive patients with metastatic breast cancer. It was shown in pre-clinical studies and in one Phase 1 study to stimulate a potent polyclonal antibody response to HER-2/neu. HER-Vaxx has stimulated the production of HER-2 antibodies in early-stage cancer patients enrolled in the initial clinical trial. The Company is also developing mimotope-based immunotherapies against validated and oncology targets.

  Be the first to like this.
 


 

440  721  667  2501 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 IMU 0.053+0.008 
 TTB 0.115+0.037 
 NHL 0.069-0.006 
 HMD 0.27+0.055 
 ECT 0.0010.00 
 SRN 0.0030.00 
 CIO 0.0040.00 
 DTR 0.0020.00 
 AZM 0.0320.00 
 KLH 0.0010.00 
Partners & Brokers